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NOTABLENOTES
Carlo Forlanini, the DermatologistWho Invented the Cure for Pulmonary Tuberculosis
Filippo Pesapane, MD; Antonella Coggi, MD; Raffaele Gianotti, MD
Carlo Forlanini was born in 1847 in Milan, Italy, and was the son of Fed-
erico Forlanini, the primary doctor fromMilan’s Fatebenefratelli Hospi-
tal. Carlowas theelderbrotherofEnricoForlanini, an inventor andaero-
nautical pioneer well known for his works on helicopters, aircraft,
hydrofoils, and dirigibles. Forlanini joined the faculty ofmedicine at the
University of Pavia. In 1866, he volunteered to serve under Giuseppe
Garibaldi, and in 1870he graduatedwith a thesis focusedon cutaneous
inflammationentitled“ContribuzioneallaTeoriadellaPiogenesi.”1Aclose
friend in his student days was Camillo Golgi, a man who would later
achieve eminence as a histologist and receive theNobel Prize in 1906.2
Milan'smain hospital, “OspedaleMaggiore Policlinico” (now “Fond-
azioneCa’Granda”), attractedForlanini, andhewasaccepted in 1871.He
spent the next 13 years working in the departments of chronic dis-
eases, eye diseases, and, particularly, skin diseases. In January 1876, he
was appointed the head of the skin department, a post hewould retain
for the next 6 years in order to continue his interest in studying
tuberculosis.1
In the 1882, the same year that Robert Koch discovered of the tu-
bercle bacillus, Forlanini introduced a new treatment of pulmonary tu-
berculosis: the artificial pneumothorax.Hebased this treatment on the
intuition that to heal from lung tuberculosis it was necessary suppress
its function, or rather to collapse it to eliminate the respiratory trauma.
The method is based on the technique of “collassoterapia,” which For-
lanini also invented. The techniqueconsists of introducing inert gas into
the pleural cavity corresponding to the injured lung so that it is placed
in a state of functional rest to facilitate healing.3 For some 40 years be-
fore the introductionof antituberculous drugs, artificial pneumothorax
offered hope and, in many cases, healing to patients with tuberculosis
around the world.
In 1884,hewasappointedchairofClinicaPropedeuticaatTurin, Italy,
and, finally, in 1900heobtained the chair of clinicalmedicine at theUni-
versity ofPavia, an institution thatboastedaglorious tradition. Thiswas
where Giulio Bizzozero had made discoveries on the physiologic char-
acteristics of blood, where Paolo Mantegazza had signaled the impor-
tanceof theglandsof internal secretion, andwhereEdoardoBassini had
developed hismethod of treating inguinal hernia.2 By all accounts, For-
lanini was a popular teacher. Among his pupils was Scipione Riva-
Rocca,who introduced the first practical sphygmomanometer in 1896.1
In 1913, Forlanini becamea senatorof the ItalianRepublic, andat the
time of his death in 1918 he had been proposed for the Nobel Prize in
Medicine. After his death, a research fund for the study of tuberculosis
was created in his name. In 1934, the “Carlo Forlanini Institute” was
founded inRome, comprisingacomplexof sanatorium,university clinic,
laboratories museum, and research center.1
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